Medadvisor Ltd (MDR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medadvisor Ltd (MDR) has a cash flow conversion efficiency ratio of 5.093x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-8.24 Million ≈ $-5.83 Million USD) by net assets (AU$-1.62 Million ≈ $-1.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medadvisor Ltd (MDR) total market value for the company's overall valuation and market capitalisation.
Medadvisor Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Medadvisor Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medadvisor Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medadvisor Ltd ranked by their cash flow conversion efficiency. Explore Medadvisor Ltd cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Crescent NV
BR:OPTI
|
-0.688x |
|
WALKER RIVER RES CORP
F:1WV0
|
-0.019x |
|
Cielo Waste Solutions Corp
V:CMC
|
0.632x |
|
MILA RESOUR. PLC LS-01
F:HN0
|
N/A |
|
TWZ Corporation Public Company Limited
BK:TWZ
|
-0.005x |
|
CalciMedica, Inc. Common Stock
NASDAQ:CALC
|
0.731x |
|
RENEWABLE VENTURES NORDIC
F:X72
|
-0.145x |
|
Meta Epsi Tbk PT
JK:MTPS
|
0.244x |
Annual Cash Flow Conversion Efficiency for Medadvisor Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Medadvisor Ltd from 2011 to 2025. View MDR stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-1.62 Million ≈ $-1.14 Million |
AU$-14.37 Million ≈ $-10.16 Million |
8.880x | +8729.14% |
| 2024-06-30 | AU$51.58 Million ≈ $36.50 Million |
AU$5.19 Million ≈ $3.67 Million |
0.101x | +435.19% |
| 2023-06-30 | AU$48.46 Million ≈ $34.29 Million |
AU$-1.45 Million ≈ $-1.03 Million |
-0.030x | -338.61% |
| 2022-06-30 | AU$34.55 Million ≈ $24.44 Million |
AU$-236.32K ≈ $-167.21K |
-0.007x | +97.34% |
| 2021-06-30 | AU$48.85 Million ≈ $34.56 Million |
AU$-12.54 Million ≈ $-8.88 Million |
-0.257x | +49.65% |
| 2020-06-30 | AU$17.02 Million ≈ $12.04 Million |
AU$-8.68 Million ≈ $-6.14 Million |
-0.510x | +36.52% |
| 2019-06-30 | AU$8.64 Million ≈ $6.12 Million |
AU$-6.95 Million ≈ $-4.91 Million |
-0.803x | -272.90% |
| 2018-06-30 | AU$15.17 Million ≈ $10.73 Million |
AU$-3.27 Million ≈ $-2.31 Million |
-0.215x | +16.19% |
| 2017-06-30 | AU$9.35 Million ≈ $6.62 Million |
AU$-2.40 Million ≈ $-1.70 Million |
-0.257x | +75.12% |
| 2016-06-30 | AU$2.46 Million ≈ $1.74 Million |
AU$-2.55 Million ≈ $-1.80 Million |
-1.033x | -123.13% |
| 2015-06-30 | AU$-106.88K ≈ $-75.63K |
AU$-477.40K ≈ $-337.79K |
4.467x | +155.67% |
| 2014-06-30 | AU$310.98K ≈ $220.04K |
AU$-2.50 Million ≈ $-1.77 Million |
-8.024x | -2576.88% |
| 2013-06-30 | AU$11.11 Million ≈ $7.86 Million |
AU$-3.33 Million ≈ $-2.36 Million |
-0.300x | -44.27% |
| 2012-06-30 | AU$2.78 Million ≈ $1.97 Million |
AU$-577.73K ≈ $-408.78K |
-0.208x | -5068.77% |
| 2011-06-30 | AU$3.14 Million ≈ $2.22 Million |
AU$-12.62K ≈ $-8.93K |
-0.004x | -- |
About Medadvisor Ltd
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anm… Read more